Kymera Therapeutics Inc.

NASDAQ: KYMR · Real-Time Price · USD
29.94
-1.20 (-3.85%)
At close: May 14, 2025, 12:12 PM

Kymera Therapeutics Stock Forecast

Stock Price Forecast

The 15 analysts with 12-month price forecasts for KYMR stock have an median target of 56.5, with a low estimate of 44 and a high estimate of 70. The median target predicts an increase of 88.71% from the current stock price of 29.94.

Target Low Average Median High
Price 44 56.64 56.5 70
Change 46.96% 89.18% 88.71% 133.80%

Latest Analyst Insight Report

Guggenheim maintains a Buy rating on Kymera Therap... Unlock content with Pro Subscription

Updated May 12, 2025

Rating Nov 24 Dec 24 Jan 25 Feb 25 Mar 25 May 25
Strong Buy 000100
Buy 331012
Hold 110001
Sell 000000
Strong Sell 000000
Total 4 4 1 1 1 3

Financial Forecast this Year

Revenue This Year
56.95M
from 47.07M
Increased by 21.0%
Revenue Next Year
64.56M
from 56.95M
Increased by 13.4%
EPS This Year
-3.63
from -2.98
Increased by -21.8%
EPS Next Year
-4.11
from -3.63
Increased by -13.2%